Sign in
4

Changes in Ownership

Prelude Therapeutics Inc Filed Acc 0001638599-21-000590

Options or other derivatives

  • Director acquired 23,344 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
BAKER BROS. ADVISORS LP Director 2021-06-18 Grant or award · Non-Qualified Stock Options (right to buy) +23,344 23,344 I: show line 1 in the form
Loading xslF345X03/doc4_7283.xml…